Advertisement
Home 2016 April

Monthly Archives: April 2016

For patients with type 1 diabetes

Digital Assistant in Closed-Loop Control Mode Beneficial in T1DM

0
Overnight-only and 24/7 closed-loop control reduce hypoglycemia, increase time in range
Pembrolizumab (Keytruda)

AACR: Pembrolizumab Effective Against Merkel-Cell Carcinoma

0
Intravenous medication blocks programmed death 1 (PD-1) immune inhibitory pathway
A new two-step Ebola vaccine strategy has shown some promise in early clinical trials

Early Trials Offer Promising Results for 2-Step Ebola Vaccine

0
One vaccine provided first as a primer, and the second given as a booster
Metformin is associated with reduced cardiovascular mortality compared with sulfonylureas

Lower CVD Mortality for Metformin Versus Sulfonylureas

0
Large analysis found up to 40 percent lower risk of heart disease mortality versus sulfonylureas
The first case of Alzheimer's disease (AD) diagnosed in a person with HIV suggests progressive dementia in older HIV+ individuals may be due to HIV-associated neurocognitive disorder

Novel Case of Alzheimer’s Reported in HIV+ Patient

0
Amyloid PET imaging may help distinguish AD from HIV-associated neurocognitive disorder
Implantation of sliding growth guidance instrumentation LSZ-4D

Metal Up in Blood With Titanium Growth Guidance Sliding Device

0
Increased content of metal ion in blood and tissue around implanted device in children with scoliosis
Many breast cancer patients receive chemotherapy they don't need

AACR: Many Breast Cancer Patients May Not Need Chemo

0
Genetic test can help doctors determine who can safely avoid treatment after surgery
For perimenopausal and postmenopausal women

Review: Paroxetine Reduces Vasomotor Symptoms

0
Moderate quality evidence shows reduction in frequency of hot flashes with paroxetine
For renal transplant recipients

Oral Nicotinamide Safe for Renal Transplant Recipients

0
Treatment linked to nonsignificant reductions in new non-melanoma skin cancers
For patients with post-myocardial infarction heart failure

Mineralocorticoid Receptor Antagonists No Benefit Post MI

0
MRA in addition to standard therapy does not improve outcome in setting of post-MI heart failure